OM1, a health technology company focused on real-world outcomes for chronic conditions, today announced an $85 million financing led by D1 Capital Partners, Kaiser Permanente, and Breyer Capital, with participation from existing investors, including General Catalyst (GC), Polaris Partners, Scale Venture Partners, 7wire Ventures, and Glikvest.

With a focus on chronic conditions, OM1 is a real-world data, outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes. OM1's real-world evidence platform, clinical registries and AI technologies enable clients to accelerate research, to measure and benchmark health outcomes and to personalize patient care. Learn more at www.om1.com.

Real-World Data &Amp; Technology Company Om1 Closes $85 Million Financing To Make Healthcare More Measured, Precise, And Pre-Emptive

Description

Company Information

Funding Insights

Real-World Data &Amp; Technology Company Om1 Closes $85 Million Financing To Make Healthcare More Measured, Precise, And Pre-Emptive

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information